177 related articles for article (PubMed ID: 33724567)
1. Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signaling.
Ackun-Farmmer MA; Soto CA; Lesch ML; Byun D; Yang L; Calvi LM; Benoit DSW; Frisch BJ
FASEB J; 2021 Apr; 35(4):e21402. PubMed ID: 33724567
[TBL] [Abstract][Full Text] [Related]
2. MIP-1α/CCL3-expressing basophil-lineage cells drive the leukemic hematopoiesis of chronic myeloid leukemia in mice.
Baba T; Tanabe Y; Yoshikawa S; Yamanishi Y; Morishita S; Komatsu N; Karasuyama H; Hirao A; Mukaida N
Blood; 2016 May; 127(21):2607-17. PubMed ID: 27006388
[TBL] [Abstract][Full Text] [Related]
3. MIP-1α/CCL3-mediated maintenance of leukemia-initiating cells in the initiation process of chronic myeloid leukemia.
Baba T; Naka K; Morishita S; Komatsu N; Hirao A; Mukaida N
J Exp Med; 2013 Nov; 210(12):2661-73. PubMed ID: 24166712
[TBL] [Abstract][Full Text] [Related]
4. The Chemokine CCL3 Regulates Myeloid Differentiation and Hematopoietic Stem Cell Numbers.
Staversky RJ; Byun DK; Georger MA; Zaffuto BJ; Goodman A; Becker MW; Calvi LM; Frisch BJ
Sci Rep; 2018 Oct; 8(1):14691. PubMed ID: 30279500
[TBL] [Abstract][Full Text] [Related]
5. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia.
Frisch BJ; Ashton JM; Xing L; Becker MW; Jordan CT; Calvi LM
Blood; 2012 Jan; 119(2):540-50. PubMed ID: 21957195
[TBL] [Abstract][Full Text] [Related]
6. A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9.
Dash AB; Williams IR; Kutok JL; Tomasson MH; Anastasiadou E; Lindahl K; Li S; Van Etten RA; Borrow J; Housman D; Druker B; Gilliland DG
Proc Natl Acad Sci U S A; 2002 May; 99(11):7622-7. PubMed ID: 12032333
[TBL] [Abstract][Full Text] [Related]
7. Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.
Balderman SR; Li AJ; Hoffman CM; Frisch BJ; Goodman AN; LaMere MW; Georger MA; Evans AG; Liesveld JL; Becker MW; Calvi LM
Blood; 2016 Feb; 127(5):616-25. PubMed ID: 26637787
[TBL] [Abstract][Full Text] [Related]
8. Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model.
Wang R; Feng W; Wang H; Wang L; Yang X; Yang F; Zhang Y; Liu X; Zhang D; Ren Q; Feng X; Zheng G
Cancer Lett; 2020 Jan; 469():151-161. PubMed ID: 31669202
[TBL] [Abstract][Full Text] [Related]
9. Leukemia cell infiltration causes defective erythropoiesis partially through MIP-1α/CCL3.
Wang Y; Gao A; Zhao H; Lu P; Cheng H; Dong F; Gong Y; Ma S; Zheng Y; Zhang H; Zhang Y; Xu J; Zhu X; Yuan W; Zhang X; Hao S; Cheng T
Leukemia; 2016 Sep; 30(9):1897-908. PubMed ID: 27109512
[TBL] [Abstract][Full Text] [Related]
10. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.
Burger JA; Quiroga MP; Hartmann E; Bürkle A; Wierda WG; Keating MJ; Rosenwald A
Blood; 2009 Mar; 113(13):3050-8. PubMed ID: 19074730
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5.
Nishikawa G; Kawada K; Nakagawa J; Toda K; Ogawa R; Inamoto S; Mizuno R; Itatani Y; Sakai Y
Cell Death Dis; 2019 Mar; 10(4):264. PubMed ID: 30890699
[TBL] [Abstract][Full Text] [Related]
12. Osteolineage cells and regulation of the hematopoietic stem cell.
Calvi LM
Best Pract Res Clin Haematol; 2013 Sep; 26(3):249-52. PubMed ID: 24309526
[TBL] [Abstract][Full Text] [Related]
13. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.
Cuenco GM; Ren R
Oncogene; 2001 Dec; 20(57):8236-48. PubMed ID: 11781838
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia.
Yamamoto-Sugitani M; Kuroda J; Ashihara E; Nagoshi H; Kobayashi T; Matsumoto Y; Sasaki N; Shimura Y; Kiyota M; Nakayama R; Akaji K; Taki T; Uoshima N; Kobayashi Y; Horiike S; Maekawa T; Taniwaki M
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17468-73. PubMed ID: 21987825
[TBL] [Abstract][Full Text] [Related]
15. CCL3 as Possible Negative Prognostic Factor in Chronic Lymphocytic Leukemia.
Popek-Marciniec S; Zmorzyński S; Koczkodaj D; Marciniec M; Wąsik-Szczepanek E; Karczmarczyk A; Michalak-Wojnowska M; Filip A
Acta Haematol; 2023; 146(4):277-286. PubMed ID: 37015191
[TBL] [Abstract][Full Text] [Related]
16. Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia.
Sato T; Goyama S; Kataoka K; Nasu R; Tsuruta-Kishino T; Kagoya Y; Nukina A; Kumagai K; Kubota N; Nakagawa M; Arai S; Yoshimi A; Honda H; Kadowaki T; Kurokawa M
Oncogene; 2014 Oct; 33(42):5028-38. PubMed ID: 24747972
[TBL] [Abstract][Full Text] [Related]
17. CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice.
Xu L; Chen Y; Nagashimada M; Ni Y; Zhuge F; Chen G; Li H; Pan T; Yamashita T; Mukaida N; Kaneko S; Ota T; Nagata N
Metabolism; 2021 Dec; 125():154914. PubMed ID: 34656648
[TBL] [Abstract][Full Text] [Related]
18. Differential regulatory effects of chemotherapeutic protocol on CCL3_CCL4_CCL5/CCR5 axes in acute myeloid leukemia patients with monocytic lineage.
Yazdani Z; Mousavi Z; Ghasemimehr N; Kalantary Khandany B; Nikbakht R; Jafari E; Fatemi A; Hassanshahi G
Life Sci; 2020 Jan; 240():117071. PubMed ID: 31783051
[TBL] [Abstract][Full Text] [Related]
19. CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways.
Kodama T; Koma YI; Arai N; Kido A; Urakawa N; Nishio M; Shigeoka M; Yokozaki H
Lab Invest; 2020 Sep; 100(9):1140-1157. PubMed ID: 32457351
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system.
Mayotte N; Roy DC; Yao J; Kroon E; Sauvageau G
Blood; 2002 Dec; 100(12):4177-84. PubMed ID: 12393433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
